We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDRX
1151
DELISTED
Veradigm Inc. Common Stock
MDRX
$140K ﹤0.01%
+17,142
New +$140K
ADVM
1152
DELISTED
Adverum Biotechnologies
ADVM
$134K ﹤0.01%
+1,302
New +$195K
EPZM
1153
DELISTED
Epizyme, Inc
EPZM
$123K ﹤0.01%
10,358
-58,570
-85% -$785K
AXGN icon
1154
Axogen
AXGN
$2.59B
$119K ﹤0.01%
+10,195
New +$118K
INVA icon
1155
Innoviva
INVA
$1.49B
$118K ﹤0.01%
11,280
-24,413
-68% -$310K
KRP icon
1156
Kimbell Royalty Partners
KRP
$1.49B
$117K ﹤0.01%
19,227
-305
-2% -$2.46K
PAE
1157
DELISTED
PAE Incorporated Class A Common Stock
PAE
$115K ﹤0.01%
13,581
-36,230
-73% -$323K
MOV icon
1158
Movado Group
MOV
$817M
$107K ﹤0.01%
+10,747
New +$115K
BRY
1159
DELISTED
Berry Corp
BRY
$100K ﹤0.01%
31,469
FLG
1160
Flagstar Bank National Association
FLG
$5.82B
$93K ﹤0.01%
+3,740
New +$107K
LILA icon
1161
Liberty Latin America Class A
LILA
$1.67B
$91K ﹤0.01%
16,295
-994
-6% -$6.05K
ACCO icon
1162
Acco Brands
ACCO
$402M
$89K ﹤0.01%
15,314
-11,081
-42% -$72.5K
WPG
1163
DELISTED
Washington Prime Group Inc.
WPG
$80K ﹤0.01%
13,675
CSPR
1164
DELISTED
Casper Sleep Inc.
CSPR
$78K ﹤0.01%
10,847
-29,639
-73% -$247K
DNOW icon
1165
DNOW Inc
DNOW
$3.01B
$71K ﹤0.01%
+15,536
New +$118K
FNB icon
1166
FNB Corp
FNB
$6.75B
$71K ﹤0.01%
+10,487
New +$77K
PNNT
1167
Pennant Park Investment Corp
PNNT
$242M
$59K ﹤0.01%
18,589
EXTN
1168
DELISTED
Exterran Corporation
EXTN
$42K ﹤0.01%
10,143
OTLKW
1169
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$16K ﹤0.01%
125,400
AAT
1170
American Assets Trust
AAT
$1.38B
-18,517
Closed -$516K
ACI icon
1171
Albertsons Companies
ACI
$5.89B
-1,239,474
Closed -$19.5M
ADNT icon
1172
Adient
ADNT
$1.44B
-104,989
Closed -$1.72M
AEE icon
1173
Ameren
AEE
$29.6B
-66,845
Closed -$4.7M
AEM icon
1174
Agnico Eagle Mines
AEM
$91.4B
-18,498
Closed -$1.18M
AEP icon
1175
American Electric Power
AEP
$66.9B
-32,135
Closed -$2.56M

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.